Drug Information

Drug General Information
Drug ID
D0A5ZJ
Former ID
DIB008755
Drug Name
DW-1350
Synonyms
DW-1352; Osteoblast modulator (oral, osteoporosis), Dong Wha/ Teijin/ Procter & Gamble
Drug Type
Small molecular drug
Indication Osteoporosis [ICD9: 733.0, V07.4; ICD10:M80-M81, Z79.890] Terminated [548554]
Company
Dong Wha Pharmaceutical Co Ltd
Formula
C25H31N3O3S
Canonical SMILES
c1(sc(nc1c1ccc(OCCCCCOc2ccc(cc2)/C(=N\O)/N)cc1)C)C(C)C
CAS Number
CAS 491577-61-8
PubChem Compound ID
10139005
Target and Pathway
Target(s) Leukotriene B4 receptor 1 Target Info Modulator [548594]
KEGG Pathway Neuroactive ligand-receptor interaction
NetPath Pathway IL4 Signaling Pathway
Reactome Leukotriene receptors
G alpha (q) signalling events
WikiPathways Nucleotide GPCRs
GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
Spinal Cord Injury
GPCR ligand binding
GPCR downstream signaling
References
Ref 548554Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026567)
Ref 548594Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026850)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.